Trexquant Investment LP Spero Therapeutics, Inc. Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.74 - $7.44 $17,871 - $179,683	-24,151 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.87 - $15.15 $190,068 - $365,887	24,151 New	24,151 $210,000
Q4 2020 Feb 11, 2021	SELL	$11.65 - $22.07 $209,408 - $396,708	-17,975 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$8.96 - $14.12 $161,056 - $253,807	17,975 New	17,975 $201,000
Q2 2020 Aug 07, 2020	SELL	$7.27 - $14.18 $100,369 - $195,769	-13,806 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$5.27 - $10.41 $72,757 - $143,720	13,806 New	13,806 $112,000

13.9M

200

200

Ticker SPRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,067,500
Market Cap $33.7M
Description
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.